Time-dose considerations in the treatment of anal cancer.
about
Radiotherapy versus combined modality therapy for anal carcinomaImpact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canalChemo-radiation with or without mandatory split in anal carcinoma: experiences of two institutions and review of the literature.HIV- positive anal cancer: an update for the clinicianClinical experience of SIB-IMRT in anal cancer and selective literature review.Dose planning objectives in anal canal cancer IMRT: the TROG ANROTAT experienceCarcinoma of the anal canal: a local experience and review of the literature.French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patientsComparison of elective inguinal node irradiation techniques in anal cancer.Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plansDoes gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin.Sphincter preservation in anal cancer: a brief review.Prognostic factors for squamous cell cancer of the anal canal.Emerging role of intensity-modulated radiation therapy in anorectal cancer.Particle radiation therapy for gastrointestinal malignanciesIntensity-modulated radiation therapy for gastrointestinal tumors.Advances in the Management of Anal Cancer.Intensity-modulated radiotherapy for squamous cell carcinoma of the anal canal: efficacy of a low daily dose to clinically negative regions.Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute.The role of MRI in the assessment of the local status of anal carcinomas and in their management.Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I).The treatment of squamous anal carcinoma: guidelines of the Italian Society of Colo-Rectal Surgery.Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.Influence of radiation treatment technique on outcome and toxicity in anal cancer.Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.
P2860
Q24247566-83907FB8-50FE-4A7F-8C74-0010DE4A7C00Q33721749-7882A334-7249-4CA8-805C-8BABE0CE2B87Q33787728-DB534AFB-E5F2-47CC-B2E4-D49B784B03DCQ33888085-95E96145-119F-4AAB-BDE2-6EA3C15EAEFDQ34640551-D1D09E88-FD18-43E3-BAAB-5D7654257701Q34667668-C827AFA9-3C1C-450C-9680-6DA553B859A4Q35718077-76A4CD1D-0ABE-411F-B3AA-F9CEF4F748EBQ35824781-32AE26FF-136F-4592-9466-9A6E111D1E45Q36009950-51B4D756-DC93-4D2D-A5CC-BB5D910C4B03Q36196016-5435A8E5-9D5D-4802-92BA-0D2D949E88D3Q36389393-591DD931-7F6B-47FC-BBB5-A181B6C78A12Q36621336-44F67836-831D-4E8C-9E9F-764A911ED06CQ36779858-3CA248E9-15B6-41AE-9C18-7C7D70D7DD91Q37005884-85BAEC57-3D13-4411-9D26-BDC809BDAF3BQ37072485-D14CE08B-B08F-4AAD-A91A-2F811055DB91Q37134438-6BEC78AB-AE56-4B5F-B03F-067352F00682Q37153300-6E5B30F9-A6A2-43C6-9E25-CE3EE443B2C9Q37258940-CDF6AF11-7100-48C8-A94C-2B2D36131C4BQ38746232-39015E68-C337-4ADD-8BA6-FBF9BB2F4FA7Q38783988-4897D4F9-EE8E-468A-91CB-28DBC796FBE4Q39520534-7830142E-8A02-4C44-A1C5-63047E5E7740Q42467862-78A64082-5071-4DF1-80BA-8CD3B329D11FQ43453891-70A8317D-C265-47DB-8C81-06BD2AC66037Q44810868-5F20BE08-CE43-4406-B3FB-82D396F478E8Q46818658-5A7332D6-E041-4096-BE51-0B53CE979F07Q47101467-59213176-AF5A-42AD-8F97-50D906579FCFQ53236215-A810B59E-70F8-4134-89D6-ABA52EFBE224Q55250545-8C55DDCF-7E76-4466-B350-66F879719A11
P2860
Time-dose considerations in the treatment of anal cancer.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Time-dose considerations in the treatment of anal cancer.
@en
type
label
Time-dose considerations in the treatment of anal cancer.
@en
prefLabel
Time-dose considerations in the treatment of anal cancer.
@en
P2093
P1476
Time-dose considerations in the treatment of anal cancer.
@en
P2093
P304
P356
10.1016/S0360-3016(97)00329-5
P407
P577
1997-10-01T00:00:00Z